Annual Retained Earnings
-$223.45 M
-$17.41 M-8.45%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual retained earnings is -$223.45 million, with the most recent change of -$17.41 million (-8.45%) on December 31, 2023.
- During the last 3 years, APVO annual retained earnings has fallen by -$37.84 million (-20.39%).
- APVO annual retained earnings is now -203.11% below its all-time high of -$73.72 million, reached on December 31, 2017.
Performance
APVO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$241.26 M
-$5.10 M-2.16%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly retained earnings is -$241.26 million, with the most recent change of -$5.10 million (-2.16%) on September 30, 2024.
- Over the past year, APVO quarterly retained earnings has dropped by -$17.82 million (-7.97%).
- APVO quarterly retained earnings is now -277.22% below its all-time high of -$63.96 million, reached on September 30, 2017.
Performance
APVO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
APVO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | -8.0% |
| 3 y3 years | -20.4% | -8.0% |
| 5 y5 years | -75.4% | -43.7% |
APVO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | at low | -24.5% | at low |
| 5 y | 5-year | -33.1% | at low | -46.3% | at low |
| alltime | all time | -203.1% | +3.7% | -277.2% | +6.4% |
Aptevo Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$241.26 M(+2.2%) |
| Jun 2024 | - | -$236.16 M(+2.6%) |
| Mar 2024 | - | -$230.28 M(+3.1%) |
| Dec 2023 | -$223.45 M(+8.5%) | -$223.45 M(+2.7%) |
| Sep 2023 | - | -$217.54 M(+3.0%) |
| Jun 2023 | - | -$211.21 M(+3.9%) |
| Mar 2023 | - | -$203.26 M(-1.3%) |
| Dec 2022 | -$206.04 M(-3.7%) | -$206.04 M(+2.3%) |
| Sep 2022 | - | -$201.39 M(+3.9%) |
| Jun 2022 | - | -$193.75 M(-12.6%) |
| Mar 2022 | - | -$221.76 M(+3.6%) |
| Dec 2021 | -$214.06 M(+15.3%) | -$214.06 M(+3.0%) |
| Sep 2021 | - | -$207.79 M(+3.5%) |
| Jun 2021 | - | -$200.79 M(+4.1%) |
| Mar 2021 | - | -$192.86 M(+3.9%) |
| Dec 2020 | -$185.61 M | -$185.61 M(+4.0%) |
| Sep 2020 | - | -$178.55 M(+4.0%) |
| Jun 2020 | - | -$171.76 M(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$164.96 M(-1.7%) |
| Dec 2019 | -$167.86 M(+31.7%) | -$167.86 M(+5.1%) |
| Sep 2019 | - | -$159.68 M(+4.5%) |
| Jun 2019 | - | -$152.76 M(+9.6%) |
| Mar 2019 | - | -$139.43 M(+9.4%) |
| Dec 2018 | -$127.41 M(+72.8%) | -$127.41 M(+12.5%) |
| Sep 2018 | - | -$113.28 M(+12.5%) |
| Jun 2018 | - | -$100.72 M(+15.0%) |
| Mar 2018 | - | -$87.57 M(+18.8%) |
| Dec 2017 | -$73.72 M(-8.6%) | -$73.72 M(+15.3%) |
| Sep 2017 | - | -$63.96 M(-37.2%) |
| Jun 2017 | - | -$101.83 M(+12.3%) |
| Mar 2017 | - | -$90.64 M(+12.3%) |
| Dec 2016 | -$80.69 M(-65.2%) | -$80.69 M(+22.7%) |
| Sep 2016 | - | -$65.75 M(-74.5%) |
| Jun 2016 | - | -$257.72 M(+5.2%) |
| Mar 2016 | - | -$244.88 M(+5.6%) |
| Dec 2015 | -$231.99 M(+34.4%) | -$231.99 M |
| Dec 2014 | -$172.67 M | - |
FAQ
- What is Aptevo Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual retained earnings year-on-year change?
- What is Aptevo Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly retained earnings year-on-year change?
What is Aptevo Therapeutics annual retained earnings?
The current annual retained earnings of APVO is -$223.45 M
What is the all time high annual retained earnings for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual retained earnings is -$73.72 M
What is Aptevo Therapeutics annual retained earnings year-on-year change?
Over the past year, APVO annual retained earnings has changed by -$17.41 M (-8.45%)
What is Aptevo Therapeutics quarterly retained earnings?
The current quarterly retained earnings of APVO is -$241.26 M
What is the all time high quarterly retained earnings for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly retained earnings is -$63.96 M
What is Aptevo Therapeutics quarterly retained earnings year-on-year change?
Over the past year, APVO quarterly retained earnings has changed by -$17.82 M (-7.97%)